Home LiteratureArticle Details
PMID: 12583988 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Transplacental carcinogenicity of inorganic arsenic in the drinking water: induction of hepatic, ovarian, pulmonary, and adrenal tumors in mice.

Toxicology and applied pharmacology ·Vol. 186 ·No. 1 ·2003-01-01 ·Pages 7-17

Waalkes MP, Ward JM, Liu J, Diwan BA

Abstract

Arsenic is a known human carcinogen, but development of rodent models of inorganic arsenic carcinogenesis has been problematic. Since gestation is often a period of high sensitivity to chemical carcinogenesis, we performed a transplacental carcinogenicity study in mice using inorganic arsenic. Groups (n = 10) of pregnant C3H mice were given drinking water containing sodium arsenite (NaAsO(2)) at 0 (control), 42.5, and 85 ppm arsenite ad libitum from day 8 to 18 of gestation. These doses were well tolerated and body weights of the dams during gestation and of the offspring subsequent to birth were not reduced. Dams were allowed to give birth, and offspring were weaned at 4 weeks and then put into separate gender-based groups (n = 25) according to maternal exposure level. The offspring received no additional arsenic treatment. The study lasted 74 weeks in males and 90 weeks in females. A complete necropsy was performed on all mice and tissues were examined by light microscopy in a blind fashion. In male offspring, there was a marked increase in hepatocellular carcinoma incidence in a dose- related fashion (control, 12%; 42.5 ppm, 38%; 85 ppm, 61%) and in liver tumor multiplicity (tumors per liver; 5.6-fold over control at 85 ppm). In males, there was also a dose-related increase in adrenal tumor incidence and multiplicity. In female offspring, dose-related increases occurred in ovarian tumor incidence (control, 8%; 42.5 ppm, 26%; 85 ppm, 38%) and lung carcinoma incidence (control, 0%; 42.5 ppm, 4%; 85 ppm, 21%). Arsenic exposure also increased the incidence of proliferative lesions of the uterus and oviduct. These results demonstrate that oral inorganic arsenic exposure, as a single agent, can induce tumor formation in rodents and establishes inorganic arsenic as a complete transplacental carcinogen in mice. The development of this rodent model of inorganic arsenic carcinogenesis has important implications in defining the mechanism of action for this common environmental carcinogen.

MeSH Terms
Adrenal Gland Neoplasms/chemically induced,pathology Animals Arsenic Poisoning/etiology Arsenites/toxicity Chemical and Drug Induced Liver Injury/etiology,pathology Female Lung Neoplasms/chemically induced,pathology Male Maternal-Fetal Exchange Mice Mice, Inbred C57BL Ovarian Neoplasms/chemically induced,pathology Pregnancy Sodium Compounds/toxicity Water Pollutants, Chemical/toxicity
Chemicals
Arsenites Sodium Compounds Water Pollutants, Chemical sodium arsenite
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Waalkes Michael P
Inorganic Carcinogenesis Section, Laboratory of Comparative Carcinogenesis, National Cancer Institute at the National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA. waalkes@niehs.nih.gov
Ward Jerrold M
Liu Jie
Diwan Bhalchandra A
Article Info
Journal
Toxicology and applied pharmacology
Abbr.
Toxicol Appl Pharmacol
ISSN
0041-008X
Published
2003-01-01
Pages
7-17
Language
English
Region
United States
NLM ID
0416575
Subset
IM
Grants
NCI NIH HHS · N01-CO-12400 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com